Trial intelligence / Profile preview

Oral Corticosteroids and Olfactory Training for COVID-19 Olfactory Dysfunction

NCT05421195Unknown

Sponsor
Eye and ENT Hospital of Fudan University
Start
Jun 2022
Primary completion
Feb 2023
Countries
1
01

Overview

Randomised, open-label trial of corticosteroids in Olfactory dysfunction (2 arms), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoint: Olfactory function test result (TDI) at 3 months. Status: unknown.

02

Drugs

corticosteroids
03

Conditions

Olfactory dysfunction

Beyond the preview

Go deeper on NCT05421195.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05421195.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call